EU General Court issues mixed ruling in pharma TM clash
14-06-2018
Federal Circuit affirms Latuda decision in Sumitomo clash
19-04-2018
Par Pharmaceutical in pre-emptive strike to protect Latuda generic
05-01-2017
txking / iStockphoto.com
Japan-based Sumitomo Dainippon Pharma has taken on Indian generics company Emcure Pharmaceuticals over an antipsychotic drug.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Emcure, Sumitomo, Sunovion, patent, patent infringement, antipsychotics, schizophrenia, mental health, US District Court for the District of New Jersey
